Table TDI-11. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2004 for those countries supplying data – Part (viii) Number of clients using volatile inhalants as primary drug

Country

<15

15-19

20-24

25-29

30-34

35-39

40-44

45+

Age known

Age not known

Total

Czech Republic

13

18

0

0

0

0

0

0

31

2

33

Denmark

0

0

0

0

0

0

0

0

0

0

0

Germany

14

26

3

0

0

0

0

0

43

9

52

Greece

1

1

0

0

0

0

0

0

2

0

2

Italy

0

83

0

7

0

0

0

0

90

53

143

Cyprus

0

0

0

0

0

0

0

0

0

0

0

Latvia

19

2

0

0

0

0

0

0

21

3

24

Netherlands

1

1

0

0

0

0

0

0

2

1

3

Slovenia

0

0

0

0

0

0

0

0

0

0

0

Slovakia

19

21

2

0

0

0

0

0

42

0

42

Finland

1

1

0

0

0

0

0

0

2

1

3

Sweden

2

2

 

0

0

0

0

0

4

0

4

Bulgaria

0

1

1

0

0

0

0

0

0

0

0

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2004 Reitox national reports - Table TDI outpatient treatment centres

Data filter | tditab11h-en.xml